BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 15642668)

  • 1. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
    Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
    Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant myeloid transformation in congenital forms of neutropenia.
    Freedman MH; Alter BP
    Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.
    Ferry C; Ouachée M; Leblanc T; Michel G; Notz-Carrére A; Tabrizi R; Flood T; Lutz P; Fischer A; Gluckman E; Donadieu J
    Bone Marrow Transplant; 2005 Jan; 35(1):45-50. PubMed ID: 15489867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
    N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy.
    Tidow N; Pilz C; Kasper B; Welte K
    Stem Cells; 1997; 15 Suppl 1():113-9; discussion 120. PubMed ID: 9368331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
    J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].
    Zeidler C; Reiter A; Yakisan E; Koci B; Riehm H; Welte K
    Klin Padiatr; 1993; 205(4):264-71. PubMed ID: 7690865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
    Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
    Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis and clinical picture of severe congenital neutropenia in Israel.
    Lebel A; Yacobovich J; Krasnov T; Koren A; Levin C; Kaplinsky C; Ravel-Vilk S; Laor R; Attias D; Ben Barak A; Shtager D; Stein J; Kuperman A; Miskin H; Dgany O; Giri N; Alter BP; Tamary H
    Pediatr Blood Cancer; 2015 Jan; 62(1):103-8. PubMed ID: 25284454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
    Freedman MH; Alter BP
    Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
    Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
    Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
    Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
    Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia.
    Carlsson G; Fasth A; Berglöf E; Lagerstedt-Robinson K; Nordenskjöld M; Palmblad J; Henter JI; Fadeel B
    Br J Haematol; 2012 Aug; 158(3):363-9. PubMed ID: 22624626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden.
    Carlsson G; Aprikyan AA; Ericson KG; Stein S; Makaryan V; Dale DC; Nordenskjöld M; Fadeel B; Palmblad J; Hentera JI
    Haematologica; 2006 May; 91(5):589-95. PubMed ID: 16670064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.
    Salehi T; Fazlollahi MR; Maddah M; Nayebpour M; Tabatabaei Yazdi M; Alizadeh Z; Eshghi P; Chavoshzadeh Z; Movahedi M; Hamidieh AA; Cheraghi T; Pourpak Z; Moin M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):51-6. PubMed ID: 22427476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.